Low Uptake of the Second Dose of Human Papillomavirus Vaccine in Dar es Salaam, Tanzania

Cervical cancer represents the most common neoplastic pathology among women, with a high burden of morbidity and mortality globally. Tanzania is no exception. The human papillomavirus (HPV) vaccine remains the most effective intervention to address such a burden. However, the uptake of the second do...

Full description

Bibliographic Details
Main Authors: Nchang’wa Nhumba, Bruno Sunguya
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/10/11/1919
_version_ 1797463812983488512
author Nchang’wa Nhumba
Bruno Sunguya
author_facet Nchang’wa Nhumba
Bruno Sunguya
author_sort Nchang’wa Nhumba
collection DOAJ
description Cervical cancer represents the most common neoplastic pathology among women, with a high burden of morbidity and mortality globally. Tanzania is no exception. The human papillomavirus (HPV) vaccine remains the most effective intervention to address such a burden. However, the uptake of the second dose to confer full immunity remains a challenge. This study aimed to assess the uptake and factors associated with the second dose of the HPV (HPV-2) vaccine uptake among adolescents in the Ilala municipality of Dar es Salaam, Tanzania. Using a quantitative cross-sectional study, data of 389 adolescent girls was collected using a self-administered structured questionnaire. Analyses were conducted using Statistical Package for the Social Sciences (SPSS) software through descriptive and multivariate logistic regression methods to determine uptake, characteristics, and factors associated with the uptake of the second dose of the HPV vaccine. Among the 389 adolescents, the uptake of the HPV-2 vaccine dose was only 21.3%, a lower level compared with the first dose of HPV vaccine (35.2%). Factors associated with the uptake of the HPV-2 vaccine were age (AOR 0.14, <i>p</i> = 0.008), positive attitude towards the HPV-2 vaccine (AOR 2.04, <i>p</i> = 0.023), and awareness of the HPV-2 vaccine (AOR: 9.16, <i>p</i> = 0.003). In conclusion, only one in five adolescents in the Ilala municipality received a second dose of HPV vaccine. Such low uptake was associated with attitude towards the HPV vaccine and low awareness of HPV-2 vaccines. Regular community sensitization and awareness campaigns by relevant authorities and implementers may help to increase the HPV vaccine uptake.
first_indexed 2024-03-09T17:56:59Z
format Article
id doaj.art-3ea0a7c7d9b848b0a4ce6945fce1a6c6
institution Directory Open Access Journal
issn 2076-393X
language English
last_indexed 2024-03-09T17:56:59Z
publishDate 2022-11-01
publisher MDPI AG
record_format Article
series Vaccines
spelling doaj.art-3ea0a7c7d9b848b0a4ce6945fce1a6c62023-11-24T10:16:36ZengMDPI AGVaccines2076-393X2022-11-011011191910.3390/vaccines10111919Low Uptake of the Second Dose of Human Papillomavirus Vaccine in Dar es Salaam, TanzaniaNchang’wa Nhumba0Bruno Sunguya1School of Public Health and Social Science, Muhimbili University of Health and Allied Sciences, Dar es Salaam 11103, TanzaniaSchool of Public Health and Social Science, Muhimbili University of Health and Allied Sciences, Dar es Salaam 11103, TanzaniaCervical cancer represents the most common neoplastic pathology among women, with a high burden of morbidity and mortality globally. Tanzania is no exception. The human papillomavirus (HPV) vaccine remains the most effective intervention to address such a burden. However, the uptake of the second dose to confer full immunity remains a challenge. This study aimed to assess the uptake and factors associated with the second dose of the HPV (HPV-2) vaccine uptake among adolescents in the Ilala municipality of Dar es Salaam, Tanzania. Using a quantitative cross-sectional study, data of 389 adolescent girls was collected using a self-administered structured questionnaire. Analyses were conducted using Statistical Package for the Social Sciences (SPSS) software through descriptive and multivariate logistic regression methods to determine uptake, characteristics, and factors associated with the uptake of the second dose of the HPV vaccine. Among the 389 adolescents, the uptake of the HPV-2 vaccine dose was only 21.3%, a lower level compared with the first dose of HPV vaccine (35.2%). Factors associated with the uptake of the HPV-2 vaccine were age (AOR 0.14, <i>p</i> = 0.008), positive attitude towards the HPV-2 vaccine (AOR 2.04, <i>p</i> = 0.023), and awareness of the HPV-2 vaccine (AOR: 9.16, <i>p</i> = 0.003). In conclusion, only one in five adolescents in the Ilala municipality received a second dose of HPV vaccine. Such low uptake was associated with attitude towards the HPV vaccine and low awareness of HPV-2 vaccines. Regular community sensitization and awareness campaigns by relevant authorities and implementers may help to increase the HPV vaccine uptake.https://www.mdpi.com/2076-393X/10/11/1919human papillomavirushuman papillomavirus vaccineuptake of HPV vaccine second doseTanzania
spellingShingle Nchang’wa Nhumba
Bruno Sunguya
Low Uptake of the Second Dose of Human Papillomavirus Vaccine in Dar es Salaam, Tanzania
Vaccines
human papillomavirus
human papillomavirus vaccine
uptake of HPV vaccine second dose
Tanzania
title Low Uptake of the Second Dose of Human Papillomavirus Vaccine in Dar es Salaam, Tanzania
title_full Low Uptake of the Second Dose of Human Papillomavirus Vaccine in Dar es Salaam, Tanzania
title_fullStr Low Uptake of the Second Dose of Human Papillomavirus Vaccine in Dar es Salaam, Tanzania
title_full_unstemmed Low Uptake of the Second Dose of Human Papillomavirus Vaccine in Dar es Salaam, Tanzania
title_short Low Uptake of the Second Dose of Human Papillomavirus Vaccine in Dar es Salaam, Tanzania
title_sort low uptake of the second dose of human papillomavirus vaccine in dar es salaam tanzania
topic human papillomavirus
human papillomavirus vaccine
uptake of HPV vaccine second dose
Tanzania
url https://www.mdpi.com/2076-393X/10/11/1919
work_keys_str_mv AT nchangwanhumba lowuptakeoftheseconddoseofhumanpapillomavirusvaccineindaressalaamtanzania
AT brunosunguya lowuptakeoftheseconddoseofhumanpapillomavirusvaccineindaressalaamtanzania